2025 연구성과 (86 / 151)
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| WoS | SCOPUS | Document Type | Document Title | Abstract | Authors | Affiliation | ResearcherID (WoS) | AuthorsID (SCOPUS) | Author Email(s) | Journal Name | JCR Abbreviation | ISSN | eISSN | Volume | Issue | WoS Edition | WoS Category | JCR Year | IF | JCR (%) | FWCI | FWCI Update Date | WoS Citation | SCOPUS Citation | Keywords (WoS) | KeywordsPlus (WoS) | Keywords (SCOPUS) | KeywordsPlus (SCOPUS) | Language | Publication Stage | Publication Year | Publication Date | DOI | JCR Link | DOI Link | WOS Link | SCOPUS Link |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ○ | Meeting Abstract | MicroRNAs as Regulators of Epithelial-Mesenchymal Transition in Colorectal Cancer Metastasis | Kim, Jihyun; Kim, Gyeonghwa; Hur, Keun | Kyungpook Natl Univ, Sch Med, Dept Biochem & Cell Biol, Daegu, South Korea; Kyungpook Natl Univ, BK21 Plus KNU Biomed Convergence Prog, Daegu, South Korea | CANCER SCIENCE | CANCER SCI | 1347-9032 | 1349-7006 | 116 | SCIE | ONCOLOGY | 2024 | 4.3 | 26.8 | 0 | English | 2025 | 2025-01 | 바로가기 | 바로가기 | |||||||||||||||||
| ○ | Article | Olaparib Plus Abiraterone in Asian Patients With Metastatic Castration-Resistant Prostate Cancer: PROpel Subset Analysis | In the phase 3 PROpel trial (NCT03732820) patients with metastatic castration-resistant prostate cancer (mCRPC) treated with olaparib plus abiraterone in the first-line setting showed significantly prolonged radiographic progression-free survival (rPFS; primary data cutoff [DCO]: 30 July 2021; hazard ratio [HR] 0.66, 95% confidence interval [CI], 0.54–0.81; p < 0.001), and at prespecified final OS analysis DCO (12 October 2022) numerically prolonged overall survival (OS; HR 0.81, 95% CI, 0.67–1.00; p = 0.054), versus placebo plus abiraterone for the global population. Here, we report efficacy, safety, and patient-reported outcome data for the Asian subset in PROpel. Eligible patients were randomly assigned (1:1) to either olaparib (300 mg twice daily) or placebo in combination with abiraterone (1000 mg once daily). The primary endpoint was investigator-assessed rPFS, and a key secondary endpoint was OS. In the Asian subset (n = 133) at primary analysis, median rPFS was 27.6 months in the olaparib plus abiraterone arm (n = 63), compared with 19.3 months in the placebo plus abiraterone arm (n = 70; HR 0.55, 95% CI, 0.32–0.95). Median OS at the final analysis was not reached in the olaparib plus abiraterone arm versus 43.7 months in the placebo plus abiraterone arm (HR 0.59, 95% CI, 0.32–1.06). The safety profile was generally similar in the Asian subset and the global population. Efficacy and safety results for olaparib plus abiraterone in the Asian subset were generally consistent with the global PROpel population supporting the combination of olaparib plus abiraterone as an important first-line treatment for consideration in Asian patients with mCRPC. Trial Registration: Clinicaltrials.gov identifier: NCT03732820. © 2025 The Author(s). Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. | Oya, Mototsugu; Joung, Jae Young; Lee, Ji Youl; Sugimoto, Mikio; Choi, Young Deuk; Hong, Jun Hyuk; Uemura, Hiroji; Nishimura, Kazuo; Tsumura, Hideyasu; Kawakami, Satoru; Hirayama, Yukiyoshi; Kwon, Tae Gyun; Kwak, Cheol; Suzuki, Hiroyoshi; Fujita, Tomoko; Nii, Masahiro; McGuinness, David; Dujka, Melanie; Poehlein, Christian; Saad, Fred; Clarke, Noel | Keio University Hospital, Tokyo, Japan; Center for Prostate Cancer, National Cancer Center, Goyang, South Korea; Seoul St Mary's Hospital, The Catholic University of Korea, Seoul, South Korea; Kagawa University Hospital, Kagawa, Japan; Yonsei University College of Medicine, Seoul, South Korea; Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea; Yokohama City University Medical Center, Yokohama, Japan; Osaka International Cancer Institute, Osaka, Japan; Kitasato University School of Medicine, Kanagawa, Sagamihara, Japan; Saitama Medical Center, Saitama Medical University, Kawagoe, Japan; Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan; Chilgok Kyungpook National University Medical Center, Daegu, South Korea; Seoul National University Hospital, Seoul National University College of Medicine, Seoul, South Korea; Toho University Sakura Medical Center, Chiba, Japan; AstraZeneca, Osaka, Japan; AstraZeneca, Osaka, Japan; AstraZeneca, Cambridge, United Kingdom; AstraZeneca, Gaithersburg, MD, United States; Merck & Co. Inc., Rahway, NJ, United States; Centre Hospitalier de l'Université de Montréal, Montreal, QC, Canada; The Christie and Salford Royal Hospital NHS Foundation Trusts and University of Manchester, Manchester, United Kingdom | 35480861100; 57222985702; 59716263000; 57206266865; 59722217400; 59701609700; 35491780600; 55730600000; 8909088100; 7201666668; 57136311900; 15073765400; 7005639032; 7406834257; 57936953900; 22938868700; 57210212379; 14321545600; 6508177148; 34868640300; 57226214420 | moto-oya@keio.jp; | Cancer Science | CANCER SCI | 1347-9032 | 1349-7006 | 116 | 6 | SCIE | ONCOLOGY | 2024 | 4.3 | 26.8 | 0 | 2025-05-07 | 0 | abiraterone; Asian; metastatic castration-resistant prostate cancer; olaparib; progression-free survival | Aged; Aged, 80 and over; Androstenes; Antineoplastic Combined Chemotherapy Protocols; Asian People; Double-Blind Method; Humans; Male; Middle Aged; Neoplasm Metastasis; Phthalazines; Piperazines; Progression-Free Survival; Prostatic Neoplasms, Castration-Resistant; abiraterone; olaparib; abiraterone; androstane derivative; antineoplastic agent; olaparib; phthalazine derivative; piperazine derivative; adult; aged; anemia; Article; Asian; asthenia; backache; cataract; constipation; controlled study; diarrhea; double blind procedure; drug safety; edema; electrocardiogram; fatigue; fever; first-line treatment; follow up; heart failure; human; hypertension; Japanese (people); major clinical study; malaise; male; metastatic castration resistant prostate cancer; multicenter study; nausea; neutropenia; nuclear magnetic resonance imaging; overall survival; patient-reported outcome; phase 3 clinical trial; progression free survival; randomized controlled trial; recombination repair; sensitivity analysis; treatment duration; vomiting; Asian; castration resistant prostate cancer; clinical trial; drug therapy; metastasis; middle aged; mortality; pathology; progression free survival; very elderly | English | Final | 2025 | 10.1111/cas.16459 | 바로가기 | 바로가기 | 바로가기 | |||||||
| ○ | ○ | Article | A new Albian genus and species and two other new species of Umenocoleidae (Dictyoptera) from South Korea | Since the first description from China, the Mesozoic dictyopteran family Umenocoleidae was recorded from the Eurasian and South American continents with 18 genera and 31 species. Here, we describe one new genus and three species from the Jinju Formation, South Korea: Umenocoleus minimus sp. nov., Pseudoblattapterix weoni gen. et sp. nov., and Petropterix koreaensis sp. nov. We also discuss three new apomorphies of the Umenocoleidae and Alienopteridae, which are 1) M, Cu and PCu1 veins form an common vein near wing base, 2) M, Cu and PCu1 veins appress to R vein and 3) CuP + PCu1 vein are not as concave as in the other Holopandictyoptera (total group of extant Blattodea and Mantodea). On the basis of these new apomorphies, we support the inclusion of the family Alienopteridae into the superfamily Umenocoleoidea. We also support the exclusions of the genera Vitisma and Permoponopterix from the Umenocoleidae family and propose to transfer the genus Permoponopterix into the Protelytroptera. (c) 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies. | Bin Lee, Soo; Nam, Gi Soo; Nel, Andre; Park, Jong Kyun | Korean Fossil Res Ctr, 50-2 Hangangro 2Ga, Seoul, South Korea; Gongju Natl Univ Educ, Dept Sci Educ, 27 Ungjinro, Gongjusi, Chungcheongnamd, South Korea; Sorbonne Univ, Univ Antilles, Inst Systemat Evolut Biodivers ISYEB, Museum Natl Hist Nat,CNRS,EPHE, CP50,57 Rue Cuvier, F-75005 Paris, France; Kyungpook Natl Univ, Coll Ecol & Environm Sci, Sangju Si 37224, Gyeongsangbuk D, South Korea | 57809940200; 57212227602; 7102516878; 37661967000 | dinos20000@naver.com; anel@mnhn.fr; | CRETACEOUS RESEARCH | CRETACEOUS RES | 0195-6671 | 1095-998X | 166 | SCIE | GEOLOGY;PALEONTOLOGY | 2024 | 1.7 | 27.0 | 6.71 | 2025-05-07 | 1 | 1 | Insecta; Polyneoptera; Umenocoleoidea; Protelytroptera; New apomorphies; Forewing venation | INSECTS; BLATTARIA; EVOLUTION; JIUQUAN; BEETLE; CHINA | Forewing venation; Insecta; New apomorphies; Polyneoptera; Protelytroptera; Umenocoleoidea | South Korea; Albian; insect; new genus; new species; wing; wing morphology | English | 2025 | 2025-02 | 10.1016/j.cretres.2024.106013 | 바로가기 | 바로가기 | 바로가기 | 바로가기 | |||
| ○ | ○ | Article | Photocatalytic degradation of rhodamine B using zinc oxide/silver nanowire nanocomposite films under ultraviolet irradiation | Water pollution from industrial and household waste presents significant environmental challenges, particularly owing to the widespread use and toxicity of organic dyes such as rhodamine B (RhB). This study investigates the photocatalytic degradation of RhB using composite films composed of zinc oxide (ZnO) and silver nanowires (AgNWs) under ultraviolet (UV) irradiation. ZnO is well known for its strong photocatalytic activity because of its high charge-carrier mobility and ability to generate reactive oxygen species (ROS). However, its relatively large bandgap (approx. 3.3 eV) limits its light absorption primarily to the UV range, restricting its photocatalytic efficiency under visible light. The incorporation of AgNWs is expected to enhance charge separation, increase electron mobility and introduce localized surface plasmon resonance effects, which contribute to improved light absorption and photocatalytic performance. The ZnO/AgNW composite films were synthesized using a sol-gel method and characterized through scanning electron microscopy and energy-dispersive X-ray spectroscopy to analyse the morphology and elemental composition, X-ray diffraction to confirm the crystallinity structure, and UV-visible spectroscopy to determine optical properties and bandgap energy. The bandgap reduction observed in ZnO/AgNW composites, as confirmed by Tauc plot analysis, is attributed to structural modifications, oxygen vacancy formation and plasmonic interactions that enhance charge transfer and light absorption. This enhanced optical response directly contributed to the superior photocatalytic efficiency of the composite. The reduction in bandgap directly influenced the photocatalytic performance of the ZnO/AgNW composites. A lower bandgap extends light absorption into the visible range, allowing the material to use a broader spectrum of incident light. Furthermore, the enhanced charge-carrier separation and increased ROS generation contributed to superior photocatalytic efficiency. As a result, the ZnO/AgNW composite films achieved a 90% degradation efficiency of RhB within 40 min of UV exposure, demonstrating a significant improvement over conventional ZnO-based photocatalysts. These findings highlight the potential of ZnO/AgNW nanocomposites as efficient, reusable and scalable solutions for water purification and environmental remediation applications. | Jang, Noah; Kim, June Soo; Kim, Hyunjun; Kim, Da Ye; Nam, Yujin; Han, Maeum; Kong, Seong Ho | Kyungpook Natl Univ, Daegu, South Korea | 58130629700; 57314355500; 59446567300; 57279831500; 57211339675; 55931924500; 57204537951 | noah7925@naver.com; junesookim@gmail.com; kimhj98@knu.ac.kr; dykim0827@gmail.com; skadb76@gmail.com; mehan@knu.ac.kr; shkong@knu.ac.kr; | ROYAL SOCIETY OPEN SCIENCE | ROY SOC OPEN SCI | 2054-5703 | 12 | 6 | SCIE | MULTIDISCIPLINARY SCIENCES | 2024 | 2.9 | 27.0 | 0 | 0 | photocatalytic degradation; rhodamine B; nanocomposite film; ZnO/Ag nanowire | DOPED ZNO; NANOSTRUCTURES; PHOTOLUMINESCENCE; DYE | nanocomposite film; photocatalytic degradation; rhodamine B; ZnO/Ag nanowire | English | 2025 | 2025-06-18 | 10.1098/rsos.241967 | 바로가기 | 바로가기 | 바로가기 | 바로가기 | ||||||
| ○ | Review | Impact Assessment and Evaluation of Micro(nano)plastics Exposure in the Human Health System: A Review | The formation of micro and nano plastics (MNPs) and their exposure to the environment and human health system are new global problems currently being studied by scientific communities. MNPs can enter the body of a person in several ways, such as through the skin, ingestion, respiration, seafood, packed food materials, water, air, and cosmetics. Organ and tissue damage may result from the reactive oxygen species imbalance. The prolonged exposure of human health to plastics and polymer additives leads to asthma, bronchitis, pneumonia, and other respiratory problems. This review analyzes the problems associated with humans and animals due to the exposure of MNPs and focuses on their impacts due to biomagnification through various biological and chemical functions. A deeper comprehension of cellular and molecular level reactions of MNP contamination to the associated environment is also discussed in this review. © 2025 Wiley-VCH GmbH. | Parthipan, P.; Sathish, V.; Rajasekar, A.; Vickram, A.S.; Thanigaivel, S.; Subbaiya, R.; Karmegam, N.; Kim, Woong; Govarthanan, M.; Seralathan, Kamala-Kannan | Department of Biotechnology, Faculty of Science and Humanities, SRM Institute of Science and Technology, Kattankulathur, Tamil Nadu, Chengalpattu, 603203, India; Joseph Arts and Science College, Thirunavalur, Tamil Nadu, Kallakurichi, 607204, India; Environmental Molecular Microbiology Research Laboratory, Department of Biotechnology, Thiruvalluvar University, Serkkadu, Tamil Nadu, Vellore, 632115, India; Department of Biosciences, Saveetha School of Engineering, Saveetha Institute of Medical and Technical Sciences, Tamil Nadu, Chennai, 602105, India; Department of Biotechnology, Faculty of Science and Humanities, SRM Institute of Science and Technology, Kattankulathur, Tamil Nadu, Chengalpattu, 603203, India; Department of Biological Sciences, School of Mathematics and Natural Sciences, The Copperbelt University, Riverside, Jambo Drive, Kitwe, P O Box 21692, Zambia; PG and Research Department of Botany, Government Arts College (Autonomous), Tamil Nadu, Salem, 636007, India; Department of Environmental Engineering, Kyungpook National University, Daegu, 41566, South Korea; Department of Environmental Engineering, Kyungpook National University, Daegu, 41566, South Korea; Division of Biotechnology, Advanced Institute of Environment and Bioscience, College of Environmental and Bioresource Sciences, Jeonbuk National University, Iksan, 54596, South Korea | 57193152696; 59925504000; 55928874800; 55257689800; 55624925900; 55263515700; 6506043230; 55581636400; 54881927600; 55664148800 | kanishkarmegam@gmail.com; kannan@jbnu.ac.kr; | Advanced Sustainable Systems | ADV SUSTAIN SYST | 2366-7486 | 2366-7486 | SCIE | GREEN & SUSTAINABLE SCIENCE & TECHNOLOGY;MATERIALS SCIENCE, MULTIDISCIPLINARY | 2024 | 6.1 | 27.1 | 0 | 2025-06-11 | 0 | emerging pollutants; health impact of pollution; microplastics; reactive oxygen species; tissue damage | River pollution; Tissue; Emerging pollutants; Health impact; Health impact of pollution; Health systems; Human health; Impact assessments; Impact evaluation; Microplastics; Reactive oxygen species; Tissue damage; Reactive oxygen species | English | Article in press | 2025 | 10.1002/adsu.202500143 | 바로가기 | 바로가기 | 바로가기 | |||||||||
| ○ | ○ | Article | Interfacial Ion Transport in Porous Polydimethylsiloxane-Polydopamine Composites for Solar Thermoelectric Conversion | Recent developments in iontronic materials and devices highlight the importance of efficient ion conduction in optimizing their performance. In particular, improving ion transport in polymer electrolytes is key to the progress of advanced energy conversion systems. This study presents a novel approach to enhance the ion conductivity of poly(ethylene oxide) (PEO)-NaOH electrolytes within porous polydimethylsiloxane (PDMS) composites. By coating PDMS with a thin layer of polydopamine (PDA) and filling it with PEO-NaOH, numerous hopping sites are generated at the PEO-PDA interface for efficient Na+ transport, thereby improving ion conductivity. Additionally, by combining the broadband absorption of PDA with the scattering properties of porous PDMS, the ability of the PDA-PDMS composite to efficiently absorb and convert solar radiation into heat is demonstrated. The generated heat is confined to the light-exposed region due to the thermal insulation provided by the porous PDMS. This confinement creates a temperature gradient across the composite, preferentially enhancing the thermal diffusion of Na+ cations over OH- anions to generate thermoelectric voltage. This unique property allows for the direct conversion of solar energy into electrical energy, offering new possibilities for sustainable and efficient energy technologies. | Biutty, Merreta Noorenza; Jang, Seo Hyun; Je, Ji Hyang; Choi, U. Hyeok; Kee, Seyoung; Kim, Yena; Kim, Jungwon; Roh, Jong Wook; Kim, Joo Hyun; Yoo, Seong Il | Pukyong Natl Univ, Dept Polymer Engn, Busan 48547, South Korea; Inha Univ, Dept Polymer Sci & Engn, Program Environm & Polymer Engn, Incheon 22212, South Korea; Korea Inst Sci & Technol KIST, Inst Adv Composite Mat, Wanju 55324, South Korea; Kyungpook Natl Univ, Dept Adv Sci & Technol Convergence, Daegu 37224, Gyeongsangbuk D, South Korea; Pukyong Natl Univ, BB21 Project Team, 45 Yongso Ro, Busan 48547, South Korea | 57214726696; 59459025800; 58875897300; 57217155958; 55925354200; 59309889000; 42161715100; 25638796100; 55720072500; 24475949500 | jkim@pknu.ac.kr; siyoo@pknu.ac.kr; | ADVANCED SUSTAINABLE SYSTEMS | ADV SUSTAIN SYST | 2366-7486 | 9 | 2 | SCIE | GREEN & SUSTAINABLE SCIENCE & TECHNOLOGY;MATERIALS SCIENCE, MULTIDISCIPLINARY | 2024 | 6.1 | 27.1 | 0 | 2025-05-07 | 0 | 0 | interface; ion transport; porous composites; solar energy conversion; thermoelectricity | CONDUCTIVITY; MEMBRANES; POWER | interface; ion transport; porous composites; solar energy conversion; thermoelectricity | Elastomers; Silicones; Solar power generation; Solid electrolytes; Thermal diffusion; Thermoelectric energy conversion; Interfacial ions; Ion conduction; Ion conductivities; Ion-transport; Poly(ethylene) oxide; Polydopamine; Porous composites; Solar energy conversions; Thermal; Thermoelectric conversion; Polydimethylsiloxane | English | 2025 | 2025-02 | 10.1002/adsu.202400509 | 바로가기 | 바로가기 | 바로가기 | 바로가기 | |||
| ○ | ○ | Review | Sustainable Approaches for Managing Phthalate Pollution: Navigating Challenges, and Establishing the Future of Environmental Protection | Phthalates have become a widespread environmental pollutant that has severe implications for aquatic and terrestrial ecosystems. They are found in various sources, including industrial processes, consumer products, and food packaging, resulting in significant environmental contamination. Their persistence and ability to bioaccumulate present significant risks, especially impacting reproductive, developmental, and endocrine systems in humans. This review explores how phthalates function as mixed micropollutants, adding complexity to their evaluation and control in environmental systems. It also focuses on remediation strategies using novel biotechnological approaches, such as enzymatic degradation, genetic engineering, microbial remediation, and nanotechnology-based approaches. Enzymatic degradation utilizes specific enzymes for the breakdown of phthalates, thereby, transforming them into less toxic metabolites. Novel genetic engineering techniques have opened possibilities for improving the breakdown of phthalates by microorganisms, offering potential solutions for more efficient remediation. Nanotechnology-based approaches showcase the effectiveness of nanomaterials in absorbing and breaking down phthalates on a molecular scale. This review also highlights the importance of microbial consortia and biochar-microbial composites for environmental restoration. The unique contribution of this review lies in its comprehensive analysis of advanced biotechnological strategies for phthalate remediation, emphasizing the synergistic potential of novel techniques to protect and safeguard the environment for future generations. | Marcharla, Eswar; Chauhan, Smarika; Hariharan, Sneha; Punniyakotti, Parthipan; Sundaram, Thanigaivel; Ganesan, Swamynathan; Kim, Woong; Govarthanan, Muthusamy | SRM Inst Sci & Technol, Fac Sci & Humanities, Dept Biotechnol, Kattankulathur 603203, Tamil Nadu, India; Kyungpook Natl Univ, Dept Environm Engn, Daegu 41566, South Korea; Saveetha Univ, Saveetha Dent Coll & Hosp, Saveetha Inst Med & Tech Sci, Dept Biomat, Chennai 600077, India | Muthusamy, Govarthanan/C-1491-2014; Sundaram, Thanigaivel/H-2860-2016; Punniyakotti, Parthipan/AAZ-3749-2021; Govarthanan, Muthusamy/C-1491-2014 | 58758495900; 57713686500; 57215688021; 59478936800; 55624925900; 57382255400; 55581636400; 54881927600 | swamynag@srmist.edu.in; gova.muthu@knu.ac.kr; | ADVANCED SUSTAINABLE SYSTEMS | ADV SUSTAIN SYST | 2366-7486 | 9 | 2 | SCIE | GREEN & SUSTAINABLE SCIENCE & TECHNOLOGY;MATERIALS SCIENCE, MULTIDISCIPLINARY | 2024 | 6.1 | 27.1 | 0 | 2025-05-07 | 0 | 0 | carcinogenicity; environmental contaminant; genotoxicity; nano-based remediation; phthalate pollution; sustainable strategies | N-BUTYL PHTHALATE; WASTE-WATER TREATMENT; ACID-ESTERS; DIBUTYL PHTHALATE; PHOTOCATALYTIC DEGRADATION; DI(2-ETHYLHEXYL) PHTHALATE; MAGNETIC NANOPARTICLES; EFFICIENT REMOVAL; HUMAN EXPOSURE; BIODEGRADATION | carcinogenicity; environmental contaminant; genotoxicity; nano-based remediation; phthalate pollution; sustainable strategies | Metabolites; Carcinogenicity; Environmental contaminant; Environmental pollutants; Enzymatic Degradation; Genotoxicities; Microbials; Nano-based remediation; Phthalate pollution; Phthalates; Sustainable strategies; Remediation | English | 2025 | 2025-02 | 10.1002/adsu.202400620 | 바로가기 | 바로가기 | 바로가기 | 바로가기 | ||
| ○ | ○ | Article | Polyhexamethylene Guanidine-Treated Cotton Fabric as Self-Decontaminating Materials for Advanced Protective Clothing Against Nerve Agents | Fabrics treated with organic catalysts containing guanidine groups have shown promise as protective materials against nerve agents. This study proposes a simple method for incorporating guanidine groups onto cotton fabric surfaces using polyhexamethylene guanidine (PHMG) to develop protective materials against nerve agents. The detoxification performance of the prepared fabric was assessed using nerve agent simulants, including dimethyl methylphosphonate (DMMP) and diisopropylfluorophosphate (DFP). PHMG-treated cotton fabric decontaminated 27.6% of DMMP and 67.2% of DFP at 32 degrees C in 2 h, with half lives of 401 and 229 min, respectively. These findings indicate that PHMG-treated cotton fabric exhibits strong detoxification performance against nerve agent simulants. Therefore, PHMG can be considered an effective organic catalyst for the simple and facile fabrication of protective materials against nerve agents. | Kwon, Woong; Jeong, Euigyung | Kyungpook Natl Univ, Dept Text Syst Engn, 80 Daehak Ro, Daegu 41566, South Korea | 57208867074; 35885596300 | wolfpack@knu.ac.kr; | FIBERS AND POLYMERS | FIBER POLYM | 1229-9197 | 1875-0052 | 26 | 7 | SCIE | MATERIALS SCIENCE, TEXTILES;POLYMER SCIENCE | 2024 | 2.3 | 27.4 | 0 | 2025-06-11 | 0 | 0 | Nerve agent; Polyhexamethylene guanidine; Protective material; Diisopropylfluorophosphate; Dimethyl methylphosphonate | CHEMICAL WARFARE AGENTS; METAL-ORGANIC FRAMEWORKS; HYDROLYSIS; DECOMPOSITION; DEGRADATION; UIO-66-NH2 | Diisopropylfluorophosphate; Dimethyl methylphosphonate; Nerve agent; Polyhexamethylene guanidine; Protective material | Agents; Construction; Cotton; Exhibitions; Guanidine; Materials; Performance; Protective Coatings; Diisopropylfluorophosphate; Dimethyl methylphosphonate; Nerve agent simulants; Nerve agents; Organic catalysts; Performance; Polyhexamethylene guanidine; Protective materials; Self-decontaminating; SIMPLE method; Protective coatings | English | 2025 | 2025-07 | 10.1007/s12221-025-01025-9 | 바로가기 | 바로가기 | 바로가기 | 바로가기 | ||
| ○ | Article | Effect modification in the impacts of body mass index change on the risk of colorectal cancer in middle-aged and older adults | Background: Effect modification by cofactors in the association between body mass index (BMI) change and colorectal cancer (CRC) risk has rarely been investigated. Methods: Cancer-free individuals who participated in the national health examinations and cancer screening at 2010 and underwent national health examination at 2014, were enrolled and followed through 2021 Results: Among 3.8 million, 42,555 patients developed CRCs. Persistent high BMI increased CRC risk comparing to persistent normal BMI. Among overweight individuals, BMI loss reduced CRC risk (adjusted hazard ratios [aHR] 0.93; 95 % confidence intervals [CIs] 0.88–0.99) and marked BMI gain (overweight to obesity II) increased CRC risk (aHR 1.91; 95 % CI 1.11–3.29). The impact of BMI change on CRC risk was significant across sex, age, and smoking status, with stronger effects in women, especially postmenopausal women. Persistent underweight in individuals over 50 years increased CRC risk (aHR 1.19; 95 % CI 1.05–1.34). Marked BMI gain increased CRC risk in men (normal to obesity I; aHR 1.21; 95 % CI 1.02–1.44) and women (overweight to obesity II; aHR 2.08; 95 % CI 1.16–3.74). Conclusions: These results highlight the hazardousness of persistent high BMI and further BMI gain with effect modification by cofactors. © 2025 | Nam, Su Youn; Jo, Junwoo; Chun, Hyonho; Jeon, Seong Woo | Department of Internal Medicine, School of Medicine, Kyungpook National University, Daegu, South Korea, Division of Gastroenterology, Kyungpook National University Chilgok Hospital, Daegu, South Korea, Integrated Research and Medical Center, Kyungpook National University Hospital, Daegu, South Korea; Department of Statistics, Kyungpook National University, Daegu, South Korea; Department of Mathematical Sciences, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, South Korea; Department of Internal Medicine, School of Medicine, Kyungpook National University, Daegu, South Korea, Division of Gastroenterology, Kyungpook National University Chilgok Hospital, Daegu, South Korea | 59901791400; 57210425017; 56678893000; 59816243100 | swjeon@knu.ac.kr; | Digestive and Liver Disease | DIGEST LIVER DIS | 1590-8658 | 1878-3562 | SCIE | GASTROENTEROLOGY & HEPATOLOGY | 2024 | 3.8 | 27.6 | 0 | 2025-06-11 | 0 | Body mass index; Colorectal cancer; Menopausal status; Sex; Smoking | English | Article in press | 2025 | 10.1016/j.dld.2025.04.048 | 바로가기 | 바로가기 | 바로가기 | ||||||||||
| ○ | ○ | Article | Korean Gastric Cancer Association-Led Nationwide Survey on Surgically Treated Gastric Cancers in 2023 | Purpose: Since 1995, the Korean Gastric Cancer Association (KGCA) has been periodically conducting nationwide surveys on patients with surgically treated gastric cancer. This study details the results of the survey conducted in 2023. Materials and Methods: The survey was conducted from March to December 2024 using a standardized case report form. Data were collected on 86 items, including patient demographics, tumor characteristics, surgical procedures, and surgical outcomes. The results of the 2023 survey were compared with those of previous surveys. Results: Data from 12,751 cases were collected from 66 institutions. The mean patient age was 64.6 years, and the proportion of patients aged >= 71 years increased from 9.1% in 1995 to 31.7% in 2023. The proportion of upper-third tumors slightly decreased to 16.8% compared to 20.9% in 2019. Early gastric cancer accounted for 63.1% of cases in 2023. Regarding operative procedures, a totally laparoscopic approach was most frequently applied (63.2%) in 2023, while robotic gastrectomy steadily increased to 9.5% from 2.1% in 2014. The most common anastomotic method was the Billroth II procedure (48.8%) after distal gastrectomy and double-tract reconstruction (51.9%) after proximal gastrectomy in 2023. However, the proportion of esophago-gastrostomy with anti-reflux procedures increased to 30.9%. The rates of post-operative mortality and overall complications were 1.0% and 15.3%, respectively. Conclusions: The results of the 2023 nationwide survey demonstrate the current status of gastric cancer treatment in Korea. This information will provide a basis for future gastric cancer research. | Kim, Dong Jin; Song, Jeong Ho; Park, Ji-Hyeon; Kim, Sojung; Park, Sin Hye; Shin, Cheol Min; Kwak, Yoonjin; Bang, Kyunghye; Gong, Chung-sik; Oh, Sung Eun; Kim, Yoo Min; Park, Young Suk; Kim, Jeesun; Jung, Ji Eun; Jung, Mi Ran; Eom, Bang Wool; Park, Ki Bum; Chung, Jae Hun; Lee, Sang-Il; Son, Young-Gil; Kim, Dae Hoon; Seo, Sang Hyuk; Lee, Sejin; Seo, Won Jun; Park, Dong Jin; Kim, Yoonhong; Kim, Jin-Jo; Park, Ki Bum; Cho, In; Ahn, Hye Seong; Oh, Sung Jin; Lee, Ju-Hee; Lee, Hayemin; Gong, Seong Chan; Choi, Changin; Park, Ji-Ho; Kim, Eun Young; Lee, Chang Min; Yun, Jong Hyuk; Oh, Seung Jong; Lee, Eunju; Jeong, Seong-A; Bae, Jung-Min; Min, Jae-Seok; Chae, Hyun-dong; Kim, Sung Gon; Park, Daegeun; Kang, Dong Baek; Kim, Hogoon; Lee, Seung Soo; Choi, Sung Il; Hwang, Seong Ho; Kim, Su-Mi; Lee, Moon Soo; Kim, Sang Hyun; Jeong, Sang-Ho; Yang, Yusung; Baik, Yonghae; Eom, Sang Soo; Jeong, Inho; Jung, Yoon Ju; Park, Jong-Min; Lee, Jin Won; Park, Jungjai; Kim, Ki Han; Lee, Kyung-Goo; Lee, Jeongyeon; Oh, Seongil; Park, Ji Hun; Kim, Jong Won | Catholic Univ Korea, Eunpyeong St Marys Hosp, Coll Med, Seoul, South Korea; Ajou Univ, Sch Med, Dept Surg, Suwon, South Korea; Gachon Univ, Gil Med Ctr, Dept Surg, Coll Med, Incheon, South Korea; Catholic Univ Korea, Seoul St Marys Hosp, Dept Gastrointestinal Surg, Seoul, South Korea; Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Seongnam, South Korea; Seoul Natl Univ, Coll Med, Dept Pathol, Seoul Natl Univ Hosp, Seoul, South Korea; Konkuk Univ, Sch Med, Konkuk Univ Med Ctr, Dept Internal Med, Seoul 143729, South Korea; Univ Ulsan, Asan Med Ctr, Dept Surg, Div Gastrointestinal Surg,Coll Med, Seoul, South Korea; Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Surg, Seoul, South Korea; Yonsei Univ, Coll Med, Severance Hosp, Dept Surg, Seoul, South Korea; Seoul Natl Univ, Bundang Hosp, Dept Surg, Seongnam, South Korea; Seoul Natl Univ Hosp, Dept Surg, Seoul, South Korea; Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Surg, Seoul, South Korea; Chonnam Natl Univ, Med Sch, Dept Surg, Gwangju, South Korea; Natl Canc Ctr, Ctr Gastr Canc, Goyang, South Korea; Kyungpook Natl Univ, Chilgok Hosp, Sch Med, Dept Surg, Daegu, South Korea; Pusan Natl Univ, Sch Med,Yangsan Hosp,Dept Surg, Res Inst Convergence Biomed Sci & Technol, Ctr Robot Surg,Div Gastrointestinal Surg, Yangsan, South Korea; Chungnam Natl Univ, Chungnam Natl Univ Hosp, Coll Med, Dept Surg, Daejeon, South Korea; Keimyung Univ, Dongsan Hosp, Dept Surg, Daegu, South Korea; Chungbuk Natl Univ, Coll Med, Dept Surg, Cheongju, South Korea; Inje Univ, Busan Paik Hosp, Dept Surg, Busan, South Korea; Jeonbuk Natl Univ Hosp, Dept Surg, Jeonju, South Korea; Korea Univ, Coll Med, Dept Surg, Div Foregut Surg, Seoul, South Korea; Univ Ulsan, Coll Med, Dept Surg, Ulsan, South Korea; Kosin Univ, Coll Med, Dept Surg, Busan, South Korea; Catholic Univ Korea, Incheon St Marys Hosp, Dept Surg, Seoul, South Korea; Catholic Univ Korea, St Vincents Hosp, Dept Surg, Seoul, South Korea; Soonchunhyang Univ, Coll Med, Dept Orthoped Surg, Bucheon Hosp, Bucheon, South Korea; Seoul Natl Univ, Boramae Med Ctr, Dept Surg, Seoul Metropolitan Govt, Seoul, South Korea; Inje Univ, Haeundae Paik Hosp, Dept Surg, Busan, South Korea; Hanyang Univ, Coll Med, Dept Surg, Seoul, South Korea; Catholic Univ Korea, Bucheon St Marys Hosp, Coll Med, Dept Surg, Seoul, South Korea; Yonsei Univ, Wonju Coll Med, Dept Surg, Wonju, South Korea; Pusan Natl Univ, Sch Med, Pusan Natl Univ Hosp, Dept Surg, Busan, South Korea; Gyeongsang Natl Univ, Gyeongsang Natl Univ Hosp, Dept Surg, Coll Med, Jinju, South Korea; Catholic Univ Korea, Uijeongbu St Marys Hosp, Coll Med, Dept Surg, Seoul, South Korea; Korea Univ, Ansan Hosp, Dept Surg, Ansan, South Korea; Soonchunhyang Univ, Coll Med, Coll Med, Cheonan Hosp, Cheonan, South Korea; Inha Univ Hosp, Inha Coll Med, Dept Orthoped Surg, Incheon, South Korea; Chung Ang Univ, Dept Surg, Gwangmyeong Hosp, Gwangmyeong, South Korea; Univ Ulsan, Coll Med, Gangneung Asan Hosp, Dept Surg, Kangnung, South Korea; Yeungnam Univ, Coll Med, Dept Surg, Daegu, South Korea; Korea Univ, Coll Med, Dept Surg, Div Foregut Surg,Anam Hosp, Seoul, South Korea; Daegu Catholic Univ, Dept Neurol, Med Ctr DCUMC, Daegu, South Korea; Konyang Univ Hosp, Dept Surg, Daejeon, South Korea; Kyung Hee Univ, Med Ctr, Dept Surg, Seoul, South Korea; Wonkwang Univ Hosp, Dept Surg, Iksan, South Korea; Chonnam Natl Univ, Dept Surg, Div Gastroenterol Surg, Med Sch, Gwangju, South Korea; Kyungpook Natl Univ, Sch Med, Dept Surg, Daegu, South Korea; Kyung Hee Univ Hosp Gangdong, Dept Surg, Seoul, South Korea; Catholic Univ Korea, Daejeon St Marys Hosp, Coll Med, Dept Surg, Seoul, South Korea; CHA Univ, CHA Bundang Med Ctr, Dept Surg, Seongnam, South Korea; Eulji Univ, Daejeon Eulji Med Ctr, Daejeon, South Korea; Soonchunhyang Univ, Sch Med, Seoul Hosp, Dept Surg, Seoul, South Korea; Gyeongsang Natl Univ, Coll Med, Gyeongsang Natl Univ Hosp, Jinju 52727, South Korea; Gyeongsang Natl Univ, Changwon Hosp, Chang Won, South Korea; Presbyterian Med Ctr, Dept Surg, Jeonju, South Korea; Dongguk Univ, Ilsan Hosp, Dept Surg, Goyang, South Korea; Inje Univ, Ilsan Paik Hosp, Dept Surg, Coll Med, Goyang, South Korea; Jeju Natl Univ, Coll Med, Dept Surg, Jeju, South Korea; Catholic Univ Korea, Yeouido St Marys Hosp, Dept Surg, Seoul, South Korea; Natl Med Ctr, Dept Surg, Seoul, South Korea; Hallym Univ, Kangnam Sacred Heart Hosp, Coll Med, Dept Thorac & Cardiovasc Surg, Seoul, South Korea; Chinjujeil Hosp, Dept Surg, Jinju, South Korea; Busan Metropolitan City Med Ctr, Dept Surg, Busan, South Korea; Myongji Hosp, Dept Surg, Goyang, South Korea; Bundang Jesaeng Hosp, Seongnam, South Korea; Cheongju St Marys Hosp, Dept Surg, Cheongju, South Korea; Sun Gen Hosp, Dept Internal Med, Daejeon, South Korea; Chung Ang Univ, Coll Med, Chung Ang Univ Hosp, Dept Surg, 102 Heukseok Ro, Seoul 06973, South Korea | Seo, Won Jun/GOV-4789-2022; OH, SUNG/P-7443-2019; park, youngsuk/AAV-3491-2020; Chung, Jae Hun/JUV-2844-2023; Lee, Chang/AAA-8912-2021; Bae, JungMin/HZJ-4281-2023; Min, Jae-Seok/ABG-5529-2022; PARK, DAEGEUN/MIU-4117-2025; Gong, chung sik/JCD-7106-2023; Lee, Eunju/KEE-6196-2024; Kim, Sumi/MYR-7102-2025; Eom, Bang/K-4412-2016; Kim, Sang Hyun/A-1380-2017; Park, Jong-Min/JXM-0130-2024 | 59711297600; 56883356500; 57216408038; 57222872769; 54414695000; 57281349000; 56049775700; 57213653127; 57189999095; 57217207416; 55043822900; 57223380460; 57224450275; 58953926200; 39861699600; 22984747200; 57220965452; 57215769958; 57216190320; 56706881600; 57203012448; 57748779700; 57218217072; 57202096954; 57189901347; 57203921332; 36013396100; 57211336629; 55503519700; 36872167500; 58791224300; 59258188800; 57215374198; 57220900065; 56555702700; 57202928322; 56597186000; 56901528900; 57929723900; 59548197200; 57216612986; 57556739000; 12797259400; 37031730000; 35729970300; 57189582472; 57225899551; 37016396400; 37101917700; 54400392100; 59727393100; 58502878600; 55694196400; 56664813500; 56995423000; 56949615000; 59548004000; 22950013300; 57413816300; 57203063904; 55837687600; 57279883300; 56571708200; 59547623000; 59547246800; 55930401400; 59547056000; 59548387400; 59547814100; 57192196582 | drholy@gmail.com; | JOURNAL OF GASTRIC CANCER | J GASTRIC CANCER | 2093-582X | 2093-5641 | 25 | 1 | SCIE | GASTROENTEROLOGY & HEPATOLOGY;ONCOLOGY | 2024 | 3.8 | 27.6 | 4.47 | 2025-05-07 | 3 | 1 | Stomach neoplasm; Health care survey; Korea | GASTRECTOMY; OUTCOMES | Health care survey; Korea; Stomach neoplasm | adult; aged; antireflux operation; Article; blood transfusion; body mass; diabetes mellitus; distal gastrectomy; endoscopic submucosal dissection; female; gastrectomy; gastroenterostomy; histology; human; hypertension; Korea; laparoscopy; lymph node metastasis; major clinical study; male; morbidity; mortality; proximal gastrectomy; stomach cancer; surgical mortality | English | 2025 | 2025-01 | 10.5230/jgc.2025.25.e8 | 바로가기 | 바로가기 | 바로가기 | 바로가기 | |
| ○ | ○ | Correction | Korean Gastric Cancer Association-Led Nationwide Survey on Surgically Treated Gastric Cancers in 2023 (vol 25, pg 115, 2025) | Kim, Dong Jin; Song, Jeong Ho; Park, Ji-Hyeon; Kim, Sojung; Park, Sin Hye; Shin, Cheol Min; Kwak, Yoonjin; Bang, Kyunghye; Gong, Chung-sik; Oh, Sung Eun; Kim, Yoo Min; Park, Young Suk; Kim, Jeesun; Jung, Ji Eun; Jung, Mi Ran; Eom, Bang Wool; Park, Ki Bum; Chung, Jae Hun; Lee, Sang-Il; Son, Young-Gil; Kim, Dae Hoon; Seo, Sang Hyuk; Lee, Sejin; Seo, Won Jun; Park, Dong Jin; Kim, Yoonhong; Kim, Jin-Jo; Park, Ki Bum; Cho, In; Ahn, Hye Seong; Oh, Sung Jin; Lee, Ju-Hee; Lee, Hayemin; Gong, Seong Chan; Choi, Changin; Park, Ji-Ho; Kim, Eun Young; Lee, Chang Min; Yun, Jong Hyuk; Oh, Seung Jong; Lee, Eunju; Jeong, Seong-A; Bae, Jung-Min; Min, Jae-Seok; Chae, Hyun-dong; Kim, Sung Gon; Park, Daegeun; Kang, Dong Baek; Kim, Hogoon; Lee, Seung Soo; Choi, Sung Il; Hwang, Seong Ho; Kim, Su-Mi; Lee, Moon Soo; Kim, Sang Hyun; Jeong, Sang-Ho; Yang, Yusung; Baik, Yonghae; Eom, Sang Soo; Jeong, Inho; Jung, Yoon Ju; Park, Jong-Min; Lee, Jin Won; Park, Jungjai; Kim, Ki Han; Lee, Kyung-Goo; Lee, Jeongyeon; Oh, Seongil; Park, Ji Hun; Kim, Jong Won | Catholic Univ Korea, Eunpyeong St Mays Hosp, Dept Surg, Coll Med,Div Gastrointestinal Surg, Seoul, South Korea; Ajou Univ, Sch Med, Dept Surg, Suwon, South Korea; Gachon Univ, Coll Med, Gil Med Ctr, Dept Surg, Incheon, South Korea; Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Div Gastrointestinal Surg,Dept Surg, Seoul, South Korea; Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Seongnam, South Korea; Seoul Natl Univ, Coll Med, Seoul Natl Univ Hosp, Dept Pathol, Seoul, South Korea; Konkuk Univ, Sch Med, Med Ctr, Dept Internal Med, Seoul, South Korea; Univ Ulsan, Coll Med, Asan Med Ctr, Div Gastrointestinal Surg,Dept Surg, Seoul, South Korea; Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Surg, Seoul, South Korea; Yonsei Univ, Coll Med, Severance Hosp, Dept Surg, Seoul, South Korea; Seoul Natl Univ, Bundang Hosp, Dept Surg, Seongnam, South Korea; Seoul Natl Univ Hosp, Dept Surg, Seoul, South Korea; Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Surg, Seoul, South Korea; Chonnam Natl Univ, Hwasun Hosp, Sch Med, Dept Surg, Gwangju, South Korea; Natl Canc Ctr, Ctr Gastr Canc, Goyang, South Korea; Kyungpook Natl Univ, Chilgok Hosp, Sch Med, Dept Surg, Daegu, South Korea; Pusan Natl Univ, Res Inst Convergence Biomed Sci & Technol, Div Gastrointestinal Surg, Ctr Robot Surg,Yangsan Hosp,Sch Med,Dept Surg, Yangsan, South Korea; Chungnam Natl Univ, Coll Med, Chungnam Natl Univ Hosp, Dept Surg, Daejeon, South Korea; Keimyung Univ, Dongsan Hosp, Dept Surg, Daegu, South Korea; Chungbuk Natl Univ, Coll Med, Dept Surg, Cheongju, South Korea; Inje Univ, Busan Paik Hosp, Dept Surg, Busan, South Korea; Jeonbuk Natl Univ Hosp, Dept Surg, Jeonju, South Korea; Korea Univ, Coll Med, Dept Surg, Div Foregut Surg, Seoul, South Korea; Univ Ulsan, Coll Med, Dept Surg, Ulsan, South Korea; Kosin Univ, Coll Med, Dept Surg, Busan, South Korea; Catholic Univ Korea, Coll Med, Incheon St Marys Hosp, Div Gastrointestinal Surg,Dept Surg, Seoul, South Korea; Catholic Univ Korea, St Vincents Hosp, Coll Med, Dept Surg, Seoul, South Korea; Soonchunhyang Univ, Coll Med, Bucheon Hosp, Dept Surg, Bucheon, South Korea; Seoul Natl Univ, Boramae Med Ctr, Seoul Metropolitan Govt, Dept Surg, Seoul, South Korea; Inje Univ, Haeundae Paik Hosp, Dept Surg, Busan, South Korea; Hanyang Univ, Coll Med, Dept Surg, Seoul, South Korea; Catholic Univ Korea, Coll Med, Dept Surg, Bucheon St Marys Hosp, Seoul, South Korea; Yonsei Univ, Wonju Coll Med, Dept Surg, Wonju, South Korea; Pusan Natl Univ, Pusan Natl Univ Hosp, Dept Surg, Sch Med, Busan, South Korea; Gyeongsang Natl Univ, Coll Med, Dept Surg, Jinju, South Korea; Gyeongsang Natl Univ Hosp, Jinju, South Korea; Catholic Univ Korea, Coll Med, Uijeongbu St Marys Hosp, Dept Surg, Seoul, South Korea; Korea Univ, Ansan Hosp, Dept Surg, Ansan, South Korea; Soonchunhyang Univ, Coll Med, Cheonan Hosp, Dept Surg, Cheonan, South Korea; Inha Univ, Coll Med, Inha Univ Hosp, Dept Surg, Incheon, South Korea; Chung Ang Univ, Coll Med, Gwangmyeong Hosp, Dept Surg, Gwangmyeong, South Korea; Univ Ulsan, Coll Med, Gangneung Asan Hosp, Dept Surg, Kangnung, South Korea; Yeungnam Univ, Coll Med, Dept Surg, Daegu, South Korea; Korea Univ, Anam Hosp, Coll Med, Div Foregut Surg,Dept Surg, Seoul, South Korea; Daegu Catholic Univ Med Ctr, Dept Surg, Daegu, South Korea; Konyang Univ Hosp, Dept Surg, Daejeon, South Korea; Kyung Hee Univ, Dept Surg, Med Ctr, Seoul, South Korea; Wonkwang Univ Hosp, Dept Surg, Iksan, South Korea; Chonnam Natl Univ, Sch Med, Chonnam Natl Univ Hosp, Dept Surg, Gwangju, South Korea; Kyungpook Natl Univ, Sch Med, Dept Surg, Daegu, South Korea; Kyung Hee Univ Hosp Gangdong, Dept Surg, Seoul, South Korea; Catholic Univ Korea, Coll Med, Dept Surg, Daejeon St Marys Hosp, Seoul, South Korea; CHA Univ, CHA Bundang Med Ctr, Dept Surg, Seongnam, South Korea; Daejeon Eulji Med Ctr, Dept Surg, Daejeon, South Korea; Soonchunhyang Univ, Dept Surg, Seoul Hosp, Sch Med, Seoul, South Korea; Gyeongsang Natl Univ, Dept Surg, Coll Med, Chang Won, South Korea; Gyeongsang Natl Univ, Changwon Hosp, Chang Won, South Korea; Presbyterian Med Ctr, Dept Surg, Jeonju, South Korea; Dongguk Univ, Dept Surg, Ilsan Hosp, Goyang, South Korea; Inje Univ, Dept Surg, Ilsan Paik Hosp, Coll Med, Goyang, South Korea; Jeju Natl Univ, Dept Surg, Coll Med, Jeju, South Korea; Catholic Univ Korea, Dept Surg, Coll Med, Yeouido St Marys Hosp, Seoul, South Korea; Natl Med Ctr, Dept Surg, Seoul, South Korea; Hallym Univ Korea, Dept Surg, Chuncheon Sacred Heart Hosp, Coll Med, Chunchon, South Korea; Chinjujeil Hosp, Dept Surg, Jinju, South Korea; Busan Metropolitan City Med Ctr, Dept Surg, Busan, South Korea; Hanyang Univ, Dept Surg, Myongji Hosp, Coll Med, Goyang, South Korea; Bundang Jesaeng Hosp, Seongnam, South Korea; Cheongju St Marys Hosp, Dept Surg, Cheongju, South Korea; Sun Med Ctr Hosp, Dept Gen Surg, Daejeon, South Korea; Chung Ang Univ, Coll Med, Chung Ang Univ Hosp, Dept Surg, Seoul, South Korea | Seo, Won Jun/GOV-4789-2022; Lee, Chang/AAA-8912-2021; OH, SUNG/P-7443-2019; Min, Jae-Seok/ABG-5529-2022; Kim, Sumi/MYR-7102-2025; Bae, JungMin/HZJ-4281-2023; Eom, Bang/K-4412-2016; Chung, Jae Hun/JUV-2844-2023; Gong, chung sik/JCD-7106-2023 | 59778858700; 56883356500; 57216408038; 57222872769; 59607704100; 59668844600; 56049775700; 57213653127; 57189999095; 57217207416; 59778183700; 57223380460; 57224450275; 58953926200; 39861699600; 22984747200; 57220965452; 57215769958; 57216190320; 59739276500; 59739174300; 59778585400; 57218217072; 57202096954; 57189901347; 57203921332; 59777919500; 57211336629; 55503519700; 36872167500; 59778183800; 59258188800; 57215374198; 59778722000; 59778858800; 57202928322; 56597186000; 56901528900; 57929723900; 59548197200; 57216612986; 57556739000; 12797259400; 59707034700; 59777919600; 57189582472; 57225899551; 37016396400; 59778183900; 59778184000; 25959932300; 58502878600; 59778450500; 59778047200; 56995423000; 57049715000; 59548004000; 22950013300; 57413816300; 57203063904; 55837687600; 57279883300; 56571708200; 59547623000; 59547246800; 55930401400; 59547056000; 59548387400; 59547814100; 57192196582 | JOURNAL OF GASTRIC CANCER | J GASTRIC CANCER | 2093-582X | 2093-5641 | 25 | 2 | SCIE | GASTROENTEROLOGY & HEPATOLOGY;ONCOLOGY | 2024 | 3.8 | 27.6 | N/A | 0 | 0 | adolescent; aged; child; clinical article; complication; controlled study; crossover procedure; double blind procedure; erratum; female; human; human tissue; major clinical study; pharmacoeconomics; randomized controlled trial; school child; special situation for pharmacovigilance; surgery | English | 2025 | 2025-04 | 10.5230/jgc.2025.25.e25 | 바로가기 | 바로가기 | 바로가기 | 바로가기 | |||||||
| ○ | ○ | Article | Korean Practice Guidelines for Gastric Cancer 2024: An Evidence-based, Multidisciplinary Approach (Update of 2022 Guideline) | Gastric cancer is one of the most common cancers in both Korea and worldwide. Since 2004, the Korean Practice Guidelines for Gastric Cancer have been regularly updated, with the 4th edition published in 2022. The 4th edition was the result of a collaborative work by an interdisciplinary team, including experts in gastric surgery, gastroenterology, endoscopy, medical oncology, abdominal radiology, pathology, nuclear medicine, radiation oncology, and guideline development methodology. The current guideline is the 5th version, an updated version of the 4th edition. In this guideline, 6 key questions (KQs) were updated or proposed after a collaborative review by the working group, and 7 statements were developed, or revised, or discussed based on a systematic review using the MEDLINE, Embase, Cochrane Library, and KoreaMed database. Over the past 2 years, there have been significant changes in systemic treatment, leading to major updates and revisions focused on this area. Additionally, minor modifications have been made in other sections, incorporating recent research findings. The level of evidence and grading of recommendations were categorized according to the Grading of Recommendations, Assessment, Development and Evaluation system. Key factors for recommendation included the level of evidence, benefit, harm, and clinical applicability. The working group reviewed and discussed the recommendations to reach a consensus. The structure of this guideline remains similar to the 2022 version. Earlier sections cover general considerations, such as screening, diagnosis, and staging of endoscopy, pathology, radiology, and nuclear medicine. In the latter sections, statements are provided for each KQbased on clinical evidence, with flowcharts supporting these statements through meta-analysis and references. This multidisciplinary, evidence-based gastric cancer guideline aims to support clinicians in providing optimal care for gastric cancer patients. | Kim, In-Ho; Kang, Seung Joo; Choi, Wonyoung; Seo, An Na; Eom, Bang Wool; Kang, Beodeul; Kim, Bum Jun; Min, Byung-Hoon; Tae, Chung Hyun; Choi, Chang In; Lee, Choong-kun; An, Ho Jung; Byun, Hwa Kyung; Im, Hyeon-Su; Kim, Hyung-Don; Cho, Jang Ho; Pak, Kyoungjune; Kim, Jae-Joon; Bae, Jae Seok; Yu, Jeong Il; Lee, Jeong Won; Choi, Jungyoon; Kim, Jwa Hoon; Choi, Miyoung; Jung, Mi Ran; Seo, Nieun; Eom, Sang Soo; Ahn, Soomin; Kim, Soo Jin; Lee, Sung Hak; Lim, Sung Hee; Kim, Tae-Han; Han, Hye Sook | Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Internal Med,Div Med Oncol, Seoul, South Korea; Seoul Natl Univ Hosp, Healthcare Syst Gangnam Ctr, Dept Internal Med, Seoul, South Korea; Natl Canc Ctr, Ctr Gastr Canc, Goyang, South Korea; Kyungpook Natl Univ, Sch Med, Dept Pathol, Daegu, South Korea; CHA Univ, CHA Bundang Med Ctr, Dept Internal Med, Med Oncol, Seongnam, South Korea; Hallym Univ, Sacred Heart Hosp, Dept Internal Med, Coll Med,Med Ctr, Anyang, South Korea; Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med, Seoul, South Korea; Ewha Womans Univ, Coll Med, Dept Internal Med, Seoul, South Korea; Pusan Natl Univ Hosp, Dept Surg, Busan, South Korea; Yonsei Univ, Coll Med, Dept Internal Med, Div Med Oncol,Yonsei Canc Ctr, Seoul, South Korea; Catholic Univ Korea, St Vincents Hosp, Dept Internal Med, Div Oncol,Coll Med, Suwon, South Korea; Yonsei Univ, Coll Med, Yongin Severance Hosp, Dept Radiat Oncol, Yongin, South Korea; Univ Ulsan, Coll Med, Dept Hematol & Oncol, Ulsan Univ Hosp, Ulsan, South Korea; Univ Ulsan, Coll Med, Asan Med Ctr, Dept Oncol, Seoul, South Korea; Gachon Univ, Dept Internal Med, Div Med Oncol, Gil Med Ctr,Coll Med, Incheon, South Korea; Pusan Natl Univ, Pusan Natl Univ Hosp, Sch Med, Dept Nucl Med, Busan 607739, South Korea; Pusan Natl Univ, Pusan Natl Univ Hosp, Sch Med, Biomed Res Inst, Busan, South Korea; Pusan Natl Univ, Yangsan Hosp, Dept Internal Med, Div Hematol & Oncol, Yangsan, South Korea; Seoul Natl Univ, Seoul Natl Univ Hosp, Dept Radiol, Coll Med, Seoul, South Korea; Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Dept Radiat Oncol, Seoul, South Korea; Soonchunhyang Univ, Cheonan Hosp, Dept Nucl Med, Cheonan, South Korea; Korea Univ, Coll Med, Dept Internal Med, Div Oncol Hematol,Ansan Hosp, Ansan, South Korea; Korea Univ, Anam Hosp, Dept Internal Med, Div Med Oncol,Coll Med, Seoul, South Korea; Natl Evidence Based Healthcare Collaborating Agcy, Seoul, South Korea; Chonnam Natl Univ, Med Sch, Dept Orthoped Surg, Gwangju, South Korea; Yonsei Univ, Coll Med, Dept Radiol, Seoul, South Korea; Inje Univ, Ilsan Paik Hosp, Dept Surg, Coll Med, Goyang, South Korea; Sungkyunkwan Univ, Samsung Med Ctr, Dept Pathol & Translat Med, Sch Med, Seoul, South Korea; Natl Canc Ctr, Dept Radiol, Goyang, South Korea; Catholic Univ Korea, Dept Hosp Pathol, Seoul St Marys Hosp, Coll Med, Seoul, South Korea; Samsung Med Ctr, Dept Internal Med, Div Hematol Oncol, Seoul, South Korea; Gyeongsang Natl Univ, Changwon Hosp, Dept Surg, 11 Samjeongja Ro, Chang Won 51472, South Korea; Chungbuk Natl Univ, Coll Med, Chungbuk Natl Univ Hosp, Dept Internal Med, 776 1sunhwan Ro, Cheongju 28644, South Korea | ; Choi, Chang/ABH-6588-2020; Yu, Jeong Il/MTC-0984-2025; Eom, Bang/K-4412-2016; Eom, Bang Wool/K-4412-2016; Kim, SooJin/LNP-4493-2024; Lee, Choong-kun/MYS-5687-2025; Choi, Jungyoon/AAA-3883-2021; Kim, Jin Il/JWP-3629-2024; Pak, Kyoungjune/CAE-5230-2022; Choi, Miyoung/HZH-8501-2023; Bae, Jaeseok/T-9071-2019 | 55477690000; 51261274600; 55904980100; 59149846900; 22984747200; 55533314700; 57191250433; 7202932034; 35211966400; 56555702700; 57196253383; 24466611800; 56715018100; 57205241250; 56526231200; 56606547300; 36599049000; 57201935527; 57188841985; 35212472500; 56675072800; 57061142100; 57189064876; 57129603200; 39861699600; 54387409200; 57413816300; 54893655800; 59537974200; 57203597873; 55757077600; 56706674700; 7401969147 | taehan.email@gmail.com; hyesukhan@chungbuk.ac.kr; | JOURNAL OF GASTRIC CANCER | J GASTRIC CANCER | 2093-582X | 2093-5641 | 25 | 1 | SCIE | GASTROENTEROLOGY & HEPATOLOGY;ONCOLOGY | 2024 | 3.8 | 27.6 | 17.86 | 2025-05-07 | 8 | 7 | Stomach neoplasms; Chemotherapy; Endoscopy; Surgery; Guidelines | ENDOSCOPIC SUBMUCOSAL DISSECTION; LONG-TERM OUTCOMES; LYMPH-NODE METASTASIS; ASSISTED DISTAL GASTRECTOMY; RANDOMIZED CLINICAL-TRIAL; PYLORUS-PRESERVING GASTRECTOMY; MULTIDETECTOR-ROW CT; PHASE-III TRIAL; ROUX-EN-Y; GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA | Chemotherapy; Endoscopy; Guidelines; Stomach neoplasms; Surgery | Article; cancer patient; chronology; clinical practice guideline; computer assisted tomography; controlled study; diagnostic test accuracy study; diffusion weighted imaging; electrogastrography; endoscopy; evidence based practice; gastroscopy; GRADE approach; high throughput sequencing; human; immunohistochemistry; Korean (people); lymph node metastasis; meta analysis; multidisciplinary team; nuclear magnetic resonance imaging; positron emission tomography-computed tomography; practice guideline; quality control; radiology; randomized controlled trial (topic); receiver operating characteristic; sensitivity and specificity; stomach cancer; stomach tumor; systematic review; systemic therapy; tumor volume | English | 2025 | 2025-01 | 10.5230/jgc.2025.25.e11 | 바로가기 | 바로가기 | 바로가기 | 바로가기 | |
| ○ | ○ | Article | Management and Collection of Occupational Data for Health (ODH) in National Public Health Statistics: Evaluation and Recommendations for Korea | Background: The aims of this study are to examine how occupation-related data and information for health (ODH) are collected and managed from census-based surveys and potential occupational illness and injuries (POIS) statistics, and to propose a national strategy for the systematic collection, analysis, and management of ODH by building on the Korean Standard Classification of Occupation (KSCO) and using a job exposure matrix (JEM). Methods: The status of the collection and management of ODH registered as national statistics, drawn not only from the census-based general population and workforce, but also from POIS statistics was reviewed and evaluated. Results: ODH from the Republic of Korea's Census of Population and Labor Force are collected and classified according to the KSCO. In contrast, national statistics on POIS are not systematically collected for KSCO coding, reflecting the lack of an KSCO and related guidelines on how to collect ODH. Key frameworks for the construction of both an KSCO and a reference JEM for public health surveillance are proposed. Conclusions: Further research is needed to develop a national system for collecting and managing ODH, which will ultimately contribute to the use of a national KSCO and the construction of JEM for public health surveillance. (c) 2024 Occupational Safety and Health Research Institute. Published by Elsevier B.V. on behalf of Institute, Occupational Safety and Health Research Institute, Korea Occupational Safety and Health Agency. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/ licenses/by-nc-nd/4.0/). | Park, Dong-Uk; Zoh, Kyung Ehi; Lee, Yun-Keun; Seo, Hoekyeong; Choi, Sangjun; Koh, Dong-Hee; Yoon, Jin-Ha; Youn, Kanwoo; Kang, Mo-Yeol; Choi, Eun Suk; Kim, Jungwon; Kim, Yangho; Paek, Domyung | Republ Korea Natl Open Univ, Dept Environm Hlth, Seoul 03087, South Korea; Seoul Natl Univ, Grad Sch Publ Hlth, Dept Publ Hlth, Seoul 08826, South Korea; Natl Canc Ctr, Natl Canc Control Inst, Goyang 10408, South Korea; Wonjin Inst Occupat & Environm Hlth, Seoul 02221, South Korea; Republ Korea Occupat Safety & Hlth Agcy, Occupat Safety & Hlth Res Inst, Ulsan 44429, South Korea; Catholic Univ Korea, Grad Sch Publ Hlth & Healthcare Management, Seoul, South Korea; Catholic Univ Korea, Coll Med, Dept Prevent Med, Seoul 06591, South Korea; Yonsei Univ, Coll Med, Dept Prevent Med, Seoul 03722, South Korea; Wonjin Green Hosp, Dept Occupat & Environm Med, Guri, South Korea; Catholic Univ Korea, Coll Med, Dept Occupat & Environm Med, Bucheon 06591, South Korea; Kyungpook Natl Univ, Coll Nursing, Daegu 41944, South Korea; Kyungpook Natl Univ, Res Inst Nursing Innovat, Daegu 41944, South Korea; Kosin Univ, Coll Med, Dept Occupat & Environm Med, Busan, South Korea; Univ Ulsan, Ulsan Univ Hosp, Coll Med, Dept Occupat & Environm Med, Ulsan 44033, South Korea | Koh, Dong-Hee/ACX-5960-2022; ZOH, KYUNG-DUK/W-1116-2019 | 7403245864; 57210012175; 16239056300; 57672484700; 55736580000; 14820885000; 59133986500; 57190335296; 55247686600; 59316988200; 55667927600; 35234002300; 6602538203 | pdw545@gmail.com; | SAFETY AND HEALTH AT WORK | SAF HEALTH WORK-KR | 2093-7911 | 2093-7997 | 16 | 1 | SCIE;SSCI | PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH | 2024 | 2.9 | 27.6 | 0 | 2025-05-07 | 0 | 0 | Job exposure matrix (JEM); Occupation-related data and information for health; Potential occupational illness and injuries; Standard Occupational Classification (KSCO) | UNITED-STATES; EXPOSURE; CANCER | Job exposure matrix (JEM); Occupation-related data and information for health; Potential occupational illness and injuries; Standard Occupational Classification (KSCO) | environmental chemical; Article; data base; decision making; demographics; disease surveillance; employment; environmental exposure; environmental health; government; health care policy; health statistics; human; Internet; interview; Korea; malignant neoplasm; occupational accident; occupational data for health; occupational disease; occupational hazard; occupational safety; population; prevalence; public health problem; public health surveillance; risk assessment; scientist; telephone interview; work environment; workforce | English | 2025 | 2025-03 | 10.1016/j.shaw.2024.11.006 | 바로가기 | 바로가기 | 바로가기 | 바로가기 | |
| ○ | ○ | Article | Prospective Multicenter Observational Study on Postoperative Quality of Life According to Type of Gastrectomy for Gastric Cancer | Purpose: This study evaluated the postoperative quality of life (QoL) after various types of gastrectomy for gastric cancer. Materials and Methods: A multicenter prospective observational study was conducted in Korea using the Korean Quality of Life in Stomach Cancer Patients Study (KOQUSS)-40, a new QoL assessment tool focusing on postgastrectomy syndrome. Overall, 496 patients with gastric cancer were enrolled, and QoL was assessed at 5 time points: preoperatively and at 1, 3, 6, and 12 months after surgery. Results: Distal gastrectomy (DG) and pylorus-preserving gastrectomy (PPG) showed significantly better outcomes than total gastrectomy (TG) and proximal gastrectomy (PG) with regard to total score, indigestion, and dysphagia. DG, PPG, and TG also showed significantly better outcomes than PG in terms of dumping syndrome and worry about cancer. Postoperative QoL did not differ significantly according to anastomosis type in DG, except for Billroth I anastomosis, which achieved better bowel habit change scores than the others. No domains differed significantly when comparing double tract reconstruction and esophagogastrostomy after PG. The total QoL score correlated significantly with postoperative body weight loss (more than 10%) and extent of resection (P<0.05 for both). Reflux as assessed by KOQUSS-40 did not correlate significantly with reflux observed on gastroscopy 1 year postoperatively (P=0.064). Conclusions: Our prospective observation using KOQUSS-40 revealed that DG and PPG lead to better QoL than TG and PG. Further study is needed to compare postoperative QoL according to anastomosis type in DG and PG. | Oh, Sung Eun; Suh, Yun-Suhk; An, Ji Yeong; Ryu, Keun Won; Cho, In; Kim, Sung Geun; Park, Ji-Ho; Hur, Hoon; Kim, Hyung-Ho; Ahn, Sang-Hoon; Hwang, Sun-Hwi; Yoon, Hong Man; Park, Ki Bum; Kim, Hyoung-Il; Kwon, In Gyu; Yang, Han-Kwang; Suh, Byoung-Jo; Jeong, Sang-Ho; Kim, Tae-Han; Kwon, Oh Kyoung; Ahn, Hye Seong; Park, Ji Yeon; Yoon, Ki Young; Son, Myoung Won; Kong, Seong-Ho; Son, Young-Gil; Song, Geum Jong; Yun, Jong Hyuk; Bae, Jung-Min; Park, Do Joong; Lee, Sol; Yang, Jun-Young; Seo, Kyung Won; Jang, You-Jin; Kang, So Hyun; Eom, Bang Wool; Lee, Joongyub; Lee, Hyuk-Joon | Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Dept Surg, Seoul, South Korea; Seoul Natl Univ, Bundang Hosp, Dept Surg, Seongnam, South Korea; Natl Canc Ctr, Ctr Gastr Canc, Goyang, South Korea; Soonchunhyang Univ, Bucheon Hosp, Dept Surg, Bucheon, South Korea; Catholic Univ Korea, Yeouido St Marys Hosp, Coll Med, Dept Surg, Seoul 150713, South Korea; Gyeongsang Natl Univ, Gyeongsang Natl Univ Hosp, Coll Med, Dept Surg, Jinju, South Korea; Ajou Univ, Sch Med, Dept Surg, Suwon, South Korea; Pusan Natl Univ, Yangsan Hosp, Sch Med, Dept Surg, Yangsan, South Korea; Kyungpook Natl Univ, Chilgok Hosp, Sch Med, Dept Surg, Daegu, South Korea; Yonsei Univ, Coll Med, Dept Surg, Seoul, South Korea; Yonsei Univ, Gangnam Severance Hosp, Coll Med, Dept Surg, Seoul, South Korea; Seoul Natl Univ, Coll Med, Dept Surg, Seoul, South Korea; Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Canc Res Inst, Seoul, South Korea; Inje Univ, Haeundae Paik Hosp, Dept Surg, Pusan 612862, South Korea; Gyeongsang Natl Univ, Changwon Hosp, Coll Med, Dept Pathol, Chang Won, South Korea; Seoul Natl Univ, Boramae Med Ctr, Dept Surg, Seoul, South Korea; Kosin Univ, Coll Med, Dept Surg, Pusan 602702, South Korea; Soonchunhyang Univ, Cheonan Hosp, Dept Surg, Cheonan, South Korea; Keimyung Univ, Dongsan Med Ctr, Dept Pediat Surg, Daegu, South Korea; Yeungnam Univ, Coll Med, Dept Surg, Daegu, South Korea; Seoul Med Ctr, Dept Surg, Seoul, South Korea; Gachon Univ, Gil Med Ctr, Dept Surg, Incheon, South Korea; Korea Univ, Guro Hosp, Coll Med, Dept Surg, Seoul, South Korea; Seoul Natl Univ, Coll Med, Dept Prevent Med, 103 Daehak Ro,Jongno-Gu, Seoul 03080, South Korea; Chung Ang Univ, Gwangmyeong Hosp, Dept Surg, Gwangmyeong, South Korea | Yang, Han/H-2458-2016; Bae, JungMin/HZJ-4281-2023; Kang, So Hyun/GRJ-2803-2022; Eom, Bang/K-4412-2016; Hur, Hoon/AAI-1396-2019 | 57217207416; 39062470900; 7202509644; 55667555300; 55503519700; 54581022500; 57202928322; 35319985500; 47962218500; 59953256100; 35268771200; 35735626600; 57220965452; 54402992800; 55618644700; 7406557280; 35320234600; 57049715000; 56706674700; 26536109900; 36872167500; 57196405216; 38362727400; 57811855500; 57226519368; 56706881600; 57200318052; 57929723900; 12797259400; 14319341400; 57211415210; 57198347353; 55436089700; 35573659700; 57195928658; 22984747200; 36196796600; 7501481303 | c5cktail@snu.ac.kr; appe98@snu.ac.kr; | JOURNAL OF GASTRIC CANCER | J GASTRIC CANCER | 2093-582X | 2093-5641 | 25 | 2 | SCIE | GASTROENTEROLOGY & HEPATOLOGY;ONCOLOGY | 2024 | 3.8 | 27.6 | 0 | 2025-05-07 | 0 | 0 | Stomach neoplasm; Quality of life; Survey and questionnaire; Gastrectomy | PYLORUS-PRESERVING GASTRECTOMY; ROUX-EN-Y; DISTAL GASTRECTOMY; VALIDATION; OUTCOMES; SYMPTOM; RECONSTRUCTION; WEIGHT; MODULE | Gastrectomy; Quality of life; Stomach neoplasm; Survey and questionnaire | adjuvant chemotherapy; anastomosis; Article; body weight; body weight loss; dysphagia; esophagogastrostomy; female; gastrectomy; human; major clinical study; male; medical record; multicenter study; observational study; postgastrectomy syndrome; quality of life; questionnaire; stomach cancer; stomach tumor | English | 2025 | 2025-04 | 10.5230/jgc.2025.25.e26 | 바로가기 | 바로가기 | 바로가기 | 바로가기 | |
| ○ | ○ | Article | Three contrasts in 3 min: Rapid, high-resolution, and bone-selective UTE MRI for craniofacial imaging with automated deep-learning skull segmentation | Purpose: Ultrashort echo time (UTE) MRI can be a radiation-free alternative to CT for craniofacial imaging of pediatric patients. However, unlike CT, bone-specific MR imaging is limited by long scan times, relatively low spatial resolution, and a time-consuming bone segmentation workflow. Methods: A rapid, high-resolution UTE technique for brain and skull imaging in conjunction with an automatic segmentation pipeline was developed. A dual-RF, dual-echo UTE sequence was optimized for rapid scan time (3 min) and smaller voxel size (0.65 mm(3)). A weighted least-squares conjugate gradient method for computing the bone-selective image improves bone specificity while retaining bone sensitivity. Additionally, a deep-learning U-Net model was trained to automatically segment the skull from the bone-selective images. Ten healthy adult volunteers (six male, age 31.5 +/- 10 years) and three pediatric patients (two male, ages 12 to 15 years) were scanned at 3 T. Clinical CT for the three patients were obtained for validation. Similarities in 3D skull reconstructions relative to clinical standard CT were evaluated based on the Dice similarity coefficient and Hausdorff distance. Craniometric measurements were used to assess geometric accuracy of the 3D skull renderings. Results: The weighted least-squares method produces images with enhanced bone specificity, suppression of soft tissue, and separation from air at the sinuses when validated against CT in pediatric patients. Dice similarity coefficient overlap was 0.86 +/- 0.05, and the 95th percentile Hausdorff distance was 1.77 +/- 0.49 mm between the full-skull binary masks of the optimized UTE and CT in the testing dataset. Conclusion: An optimized MRI acquisition, reconstruction, and segmentation workflow for craniofacial imaging was developed. | Vu, Brian-Tinh Duc; Kamona, Nada; Kim, Yohan; Ng, Jinggang J.; Jones, Brandon C.; Wehrli, Felix W.; Song, Hee Kwon; Bartlett, Scott P.; Lee, Hyunyeol; Rajapakse, Chamith S. | Univ Penn, Perelman Sch Med, Dept Radiol, Philadelphia, PA USA; Univ Penn, Sch Engn & Appl Sci, Dept Bioengn, Philadelphia, PA USA; Childrens Hosp Philadelphia, Div Plast Reconstruct & Oral Surg, Philadelphia, PA USA; Kyungpook Natl Univ, Sch Elect Engn, Daegu, South Korea; Univ Penn, Perelman Sch Med, Dept Orthopaed Surg, Philadelphia, PA USA | 58159717700; 57208866181; 59310752500; 57960008600; 57209659335; 7007158575; 55663898800; 7202248305; 57193268117; 22635351400 | bdvu@seas.upenn.edu; | MAGNETIC RESONANCE IN MEDICINE | MAGN RESON MED | 0740-3194 | 1522-2594 | 93 | 1 | SCIE | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | 2024 | 3 | 27.6 | 0 | 2025-05-07 | 1 | 1 | craniofacial imaging; dual-echo UTE; image reconstruction; skull segmentation; solid-state imaging; ultrashort echo time MRI | ZERO-ECHO-TIME; ATTENUATION CORRECTION; COMPUTED-TOMOGRAPHY; RADIATION-EXPOSURE; CORTICAL BONE; CT; RECONSTRUCTION; IMAGES; REDUCTION; HEAD | craniofacial imaging; dual-echo UTE; image reconstruction; skull segmentation; solid-state imaging; ultrashort echo time MRI | Adolescent; Adult; Algorithms; Brain; Child; Deep Learning; Female; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Skull; Tomography, X-Ray Computed; Young Adult; Brain mapping; Conjugate gradient method; Diffusion tensor imaging; Image segmentation; Magnetic resonance imaging; Nuclear magnetic resonance; Ultrasonic imaging; Craniofacial; Craniofacial imaging; Dual-echo ultrashort echo time; Images reconstruction; Pediatric patients; Skull segmentation; Solid state imaging; Ultrashort echo time; Ultrashort echo time MRI; adolescent; adult; Article; automated deep learning skull segmentation; child; computer assisted tomography; craniofacial imaging; deep learning; female; human; human experiment; image reconstruction; image segmentation; imaging; male; normal human; nuclear magnetic resonance imaging; signal noise ratio; skull; skull surgery; solid state; three-dimensional imaging; ultrashort echo time nuclear magnetic resonance imaging; algorithm; brain; deep learning; diagnostic imaging; image processing; procedures; skull; x-ray computed tomography; young adult; Computerized tomography | English | 2025 | 2025-01 | 10.1002/mrm.30275 | 바로가기 | 바로가기 | 바로가기 | 바로가기 |
페이지 이동: